Ruby Violet – Medical Cannabis Strain Profile Genetics & Composition: Ruby Violet is a hybrid cannabis strain developed by Purple City Genetics through the crossbreeding of Grape Nana and Gush Mints. This cultivar exhibits a genetic composition of approximately 60% sativa and 40% indica, providing a balanced blend of cerebral and physical effects. Aroma & Flavor Profile: Ruby Violet is noted for its complex aromatic profile, characterized by sweet, fruity undertones layered with hints of diesel and earthy notes. These sensory qualities contribute to its appeal among both recreational and medicinal users. Therapeutic Effects: According to patient-reported outcomes, Ruby Violet commonly produces effects such as relaxation, mood elevation, and enhanced creativity. Its therapeutic benefits make it a popular choice among individuals seeking relief from: Chronic stress Depressive symptoms Persistent pain conditions Primary Terpene: The dominant terpene in Ruby Violet is myrcene, a compound known for its sedative, anti-inflammatory, and analgesic properties. Myrcene is often associated with enhanced relaxation and may contribute to the strain’s calming effects. Medical Use & Considerations: Patients utilizing Ruby Violet for medical purposes often report symptom relief without excessive sedation, making it suitable for daytime or early evening use, depending on individual tolerance and response. As with all cannabis-based therapies, consultation with a healthcare provider is recommended to determine appropriate use. Patient Feedback: If you have experience using Ruby Violet for medical or personal wellness purposes, consider sharing your insights to help inform others in the medical cannabis community.